{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:02:18Z","timestamp":1780934538488,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Schu 2367\/1\u20132"],"award-info":[{"award-number":["Schu 2367\/1\u20132"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.freeradbiomed.2012.10.549","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T08:31:36Z","timestamp":1351067496000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo"],"prefix":"10.1016","volume":"54","author":[{"given":"Nina","family":"Queisser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Hey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy L.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Schupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.1.06017","article-title":"The new biology of aldosterone","volume":"186","author":"Connell","year":"2005","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J. Am. Coll. Cardiol"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","article-title":"Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers","volume":"20","author":"Gordon","year":"1993","journal-title":"Clin. Exp. Pharmacol. Physiol"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib4","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.mce.2011.09.008","article-title":"Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis","volume":"350","author":"Young","year":"2012","journal-title":"Mol. Cell. Endocrinol"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0031-1295461","article-title":"Aldosterone and the kidney","volume":"44","author":"Fourkiotis","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib7","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/1097-0142(20011101)92:9<2462::AID-CNCR1596>3.0.CO;2-L","article-title":"Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark","volume":"92","author":"Friis","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1081\/CNV-200055962","article-title":"Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review","volume":"23","author":"Moore","year":"2005","journal-title":"Cancer Invest."},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00004872-198712004-00002","article-title":"Increased intracellular calcium: from hypertension to cancer","volume":"5","author":"Meyer","year":"1987","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.HYP.28.3.321","article-title":"Cancer and hypertension: an unresolved issue","volume":"28","author":"Hamet","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.108.119966","article-title":"Reconsidering the roles of the mineralocorticoid receptor","volume":"53","author":"Funder","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/mc.20710","article-title":"Aldosterone induces oxidative stress, oxidative DNA damage and NF-kappaB-activation in kidney tubule cells","volume":"50","author":"Queisser","year":"2011","journal-title":"Mol. Carcinog"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/157488607780598296","article-title":"Hypertension, antihypertensive therapy and renal-cell cancer: a meta-analysis. Curr","volume":"2","author":"Corrao","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib14","doi-asserted-by":"crossref","first-page":"9239","DOI":"10.1158\/0008-5472.CAN-08-1310","article-title":"Angiotensin II induces DNA damage in the kidney","volume":"68","author":"Schmid","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib15","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1096\/fj.10-173286","article-title":"Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats","volume":"25","author":"Schupp","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.2010.00678.x","article-title":"Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension","volume":"160","author":"Ceron","year":"2010","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.107.099432","article-title":"Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a","volume":"52","author":"Westhoff","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2144\/000112257","article-title":"CellProfiler: free, versatile software for automated biological image analysis","volume":"42","author":"Lamprecht","year":"2007","journal-title":"Biotechniques"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib20","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/carcin\/bgq189","article-title":"Novel mechanism of regulation of the DNA repair enzyme OGG1 in tuberin-deficient cells","volume":"31","author":"Habib","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.111.181230","article-title":"Contribution of circulating angiotensinogen concentrations to variations in aldosterone and blood pressure in a group of African ancestry depends on salt intake","volume":"59","author":"Michel","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib22","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/ATVBAHA.111.242719","article-title":"Biphasic time course of the changes in aldosterone biosynthesis under high-salt conditions in dahl salt-sensitive rats","volume":"32","author":"Morizane","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib23","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.freeradbiomed.2011.08.028","article-title":"Aldosterone increases kidney tubule cell oxidants through calcium-mediated activation of NADPH oxidase and nitric oxide synthase","volume":"51","author":"Queisser","year":"2011","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1470320310391330","article-title":"Eplerenone suppresses aldosterone\/salt-induced expression of NOX-4","volume":"12","author":"Bayorh","year":"2011","journal-title":"J. Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ. Res"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00041552-200401000-00013","article-title":"Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension","volume":"13","author":"Vaziri","year":"2004","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib27","doi-asserted-by":"crossref","first-page":"26026","DOI":"10.1074\/jbc.271.42.26026","article-title":"Do nitroxide antioxidants act as scavengers of O2\u2212\u2022 or as SOD mimics?","volume":"271","author":"Krishna","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.01.003","article-title":"Effects of tempol and redox-cycling nitroxides in models of oxidative stress","volume":"126","author":"Wilcox","year":"2010","journal-title":"Pharmacol. Ther"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1523-1755.2000.00212.x","article-title":"Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat","volume":"58","author":"Chatterjee","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.genom.7.080505.115648","article-title":"DNA strand break repair and human genetic disease","volume":"8","author":"McKinnon","year":"2007","journal-title":"Annu. Rev. Genomics Hum. Genet"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib31","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1038\/sj.onc.1210868","article-title":"DNA double-strand breaks: their cellular and clinical impact?","volume":"26","author":"Jeggo","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1515\/BC.2006.050","article-title":"Mutagenesis and carcinogenesis caused by the oxidation of nucleic acids","volume":"387","author":"Nakabeppu","year":"2006","journal-title":"Biol. Chem"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib33","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1158\/0008-5472.CAN-07-0335","article-title":"The peroxisome proliferator WY-14,643 promotes hepatocarcinogenesis caused by endogenously generated oxidative DNA base modifications in repair-deficient Csbm\/m\/Ogg1\u2212\/\u2212 mice","volume":"67","author":"Trapp","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/em.20358","article-title":"The gamma-H2A.X: is it just a surrogate marker of double-strand breaks or much more?","volume":"49","author":"Ismail","year":"2008","journal-title":"Environ. Mol. Mutagen"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib35","doi-asserted-by":"crossref","first-page":"F73","DOI":"10.1152\/ajprenal.00435.2007","article-title":"Aldosterone induces mesangial cell apoptosis both in vivo and in vitro","volume":"295","author":"Mathew","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib36","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/ndt\/gfq514","article-title":"Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused rats","volume":"26","author":"Liang","year":"2011","journal-title":"Nephrol. Dial. Transplant"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.yjmcc.2005.04.001","article-title":"Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo","volume":"39","author":"Burniston","year":"2005","journal-title":"J. Mol. Cell. Cardiol"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.HYP.0000118519.66430.22","article-title":"Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone\/salt-induced hypertensive rats","volume":"43","author":"Nishiyama","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib39","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/01.HYP.0000154681.38944.9a","article-title":"Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability","volume":"45","author":"Nishiyama","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib40","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bcp.2006.07.015","article-title":"NF-kappaB activation by double-strand breaks","volume":"72","author":"Habraken","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib41","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bcp.2006.04.011","article-title":"NF-kappaB activation by reactive oxygen species: fifteen years later","volume":"72","author":"Gloire","year":"2006","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3181\/0707-MR-196","article-title":"Nuclear factor-kappaB activation: from bench to bedside","volume":"233","author":"Sethi","year":"2008","journal-title":"Exp. Biol. Med. (Maywood, NJ)"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib43","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s10495-006-0286-3","article-title":"Spironolactone induces apoptosis and inhibits NF-kappaB independent of the mineralocorticoid receptor","volume":"11","author":"Sonder","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10157-010-0373-1","article-title":"Aldosterone-induced kidney injury is mediated by NFkappaB activation. Clin","volume":"15","author":"Fukuda","year":"2011","journal-title":"Exp. Nephrol."},{"issue":"2 Part 2","key":"10.1016\/j.freeradbiomed.2012.10.549_bib45","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/01.HYP.37.2.781","article-title":"Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response","volume":"37","author":"Beswick","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/08941939.2011.592569","article-title":"Prostaglandin E2 (PGE2) in portal blood in patients with pancreatic tumor\u2014a single institution series","volume":"25","author":"Hogendorf","year":"2012","journal-title":"J. Invest. Surg"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.HYP.15.2.198","article-title":"Prostanoids and aldosterone-induced mild experimental hypertension in rats","volume":"15","author":"Hui","year":"1990","journal-title":"Hypertension"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib48","first-page":"F385","article-title":"Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species","volume":"294","author":"Jaimes","year":"2008","journal-title":"Am. J. Physiol"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0952-3278(88)90159-7","article-title":"Influence of spironolactone on urinary prostaglandin E2 and kinin excretion in rats","volume":"31","author":"Honda","year":"1988","journal-title":"Prostaglandins Leukotrienes Essent. Fatty Acids"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib50","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1440-1681.2001.03531.x","article-title":"Comparison of telemetric and tail-cuff blood pressure monitoring in adrenocorticotrophic hormone-treated rats","volume":"28","author":"Fraser","year":"2001","journal-title":"Clin. Exp. Pharmacol. Physiol"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10641960500386817","article-title":"Comparison of simultaneous measurements of blood pressure by tail-cuff and carotid arterial methods in conscious spontaneously hypertensive and Wistar-Kyoto rats","volume":"28","author":"Ibrahim","year":"2006","journal-title":"Clin. Exp. Hypertens"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/oxfordjournals.aje.a009848","article-title":"Hypertension, antihypertensive medication use, and risk of renal cell carcinoma","volume":"149","author":"Shapiro","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000334161","article-title":"Mineralocorticoid receptor blockade in chronic kidney disease","volume":"33","author":"Bomback","year":"2012","journal-title":"Blood Purif"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib54","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2215\/CJN.01040905","volume":"1","author":"Chrysostomou","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"10.1016\/j.freeradbiomed.2012.10.549_bib55","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.ajkd.2008.02.297","article-title":"Triple pharmacological blockade of the renin\u2013angiotensin\u2013aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial","volume":"52","author":"Tylicki","year":"2008","journal-title":"Am. J. Kidney Dis"}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584912017911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584912017911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:48:08Z","timestamp":1780933688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584912017911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":55,"alternative-id":["S0891584912017911"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.10.549","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood pressure has only minor influence on aldosterone-induced oxidative stress and DNA damage in vivo","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.10.549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}